JP2009525041A5 - - Google Patents

Download PDF

Info

Publication number
JP2009525041A5
JP2009525041A5 JP2008552953A JP2008552953A JP2009525041A5 JP 2009525041 A5 JP2009525041 A5 JP 2009525041A5 JP 2008552953 A JP2008552953 A JP 2008552953A JP 2008552953 A JP2008552953 A JP 2008552953A JP 2009525041 A5 JP2009525041 A5 JP 2009525041A5
Authority
JP
Japan
Prior art keywords
cancer
subject
sample
circulating
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008552953A
Other languages
English (en)
Japanese (ja)
Other versions
JP5091163B2 (ja
JP2009525041A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2007/000122 external-priority patent/WO2007088537A2/en
Publication of JP2009525041A publication Critical patent/JP2009525041A/ja
Publication of JP2009525041A5 publication Critical patent/JP2009525041A5/ja
Application granted granted Critical
Publication of JP5091163B2 publication Critical patent/JP5091163B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008552953A 2006-01-31 2007-01-31 癌またはその素因の早期検出のための方法およびキット Expired - Fee Related JP5091163B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76337806P 2006-01-31 2006-01-31
US60/763,378 2006-01-31
PCT/IL2007/000122 WO2007088537A2 (en) 2006-01-31 2007-01-31 Methods and kits for early detection of cancer or predisposition thereto

Publications (3)

Publication Number Publication Date
JP2009525041A JP2009525041A (ja) 2009-07-09
JP2009525041A5 true JP2009525041A5 (https=) 2009-12-03
JP5091163B2 JP5091163B2 (ja) 2012-12-05

Family

ID=38001788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008552953A Expired - Fee Related JP5091163B2 (ja) 2006-01-31 2007-01-31 癌またはその素因の早期検出のための方法およびキット

Country Status (12)

Country Link
US (1) US9394569B2 (https=)
EP (1) EP1994410B1 (https=)
JP (1) JP5091163B2 (https=)
AT (1) ATE486285T1 (https=)
DE (1) DE602007010108D1 (https=)
DK (1) DK1994410T3 (https=)
ES (1) ES2355388T3 (https=)
IL (1) IL193097A (https=)
PL (1) PL1994410T3 (https=)
PT (1) PT1994410E (https=)
SI (1) SI1994410T1 (https=)
WO (1) WO2007088537A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE486285T1 (de) 2006-01-31 2010-11-15 Medical Res Fund Of Tel Aviv S Verfahren zur früherkennung von krebs
WO2009074988A1 (en) * 2007-12-10 2009-06-18 Medical Research Fund Of Tel Aviv Sourasky Medical Center Methods of diagnosing cancer
EP2358912B1 (en) * 2008-10-30 2016-10-12 Caris Life Sciences Switzerland Holdings GmbH Methods for assessing rna patterns
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
GB2463401B (en) * 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
US20140148348A1 (en) 2010-01-13 2014-05-29 Christine Kuslich Dectection of gastrointestinal disorders
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
AU2011256064B2 (en) 2010-05-21 2016-09-15 The Governors Of The University Of Alberta Methods for the assessment of colorectal cancer and colorectal polyps by measurement of metabolites in urine
EP3052651B1 (en) 2013-10-01 2019-11-27 Life Technologies Corporation Systems and methods for detecting structural variants
ES2939298T3 (es) 2017-05-21 2023-04-20 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Combinación de marcadores para el diagnóstico del cáncer
EP3447154A1 (en) * 2017-08-23 2019-02-27 Instytut Genetyki Sadowej Jolanta Powierska - Czarny Method for detection of mutations, polymorphisms and specific dna sequences on dna matrices with dna imaging techniques for the use in medical diagnostics and forensic genetics
US20200408761A1 (en) 2018-02-28 2020-12-31 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Methods of diagnosing and treating bladder cancer
JP7462632B2 (ja) 2018-11-30 2024-04-05 カリス エムピーアイ インコーポレイテッド 次世代分子プロファイリング
CN110777213A (zh) * 2019-11-05 2020-02-11 武汉科技大学 一种潜伏期胃癌诊断试剂盒
WO2021112918A1 (en) 2019-12-02 2021-06-10 Caris Mpi, Inc. Pan-cancer platinum response predictor
US11840720B2 (en) 2019-12-23 2023-12-12 Metabolomic Technologies Inc. Urinary metabolomic biomarkers for detecting colorectal cancer and polyps

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07500411A (ja) * 1991-02-05 1995-01-12 ファロク セィディ 癌胎児性抗原を検出するための簡易検査法
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US7081516B2 (en) * 2002-08-26 2006-07-25 Case Western Reserve University Methods for categorizing patients
EP1497642A2 (en) * 2002-03-19 2005-01-19 Tularik, Inc. Gene amplification in cancer
US20040097448A1 (en) * 2002-11-19 2004-05-20 Isis Pharmaceuticals Inc. Modulation of CD24 expression
WO2005024603A2 (en) * 2003-09-10 2005-03-17 The Board Of Regents Of The University Of Texas System Methods for detecting, diagnosing and treating human renal cell carcinoma
CA2549913A1 (en) * 2003-11-26 2005-06-16 The Ohio State University Research Foundation Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression
CA2453198A1 (en) * 2004-01-07 2005-07-07 Wei-Ping Min Quantification and generation of immune suppressive exosomes
US7666583B2 (en) * 2004-02-19 2010-02-23 Yale University Identification of cancer protein biomarkers using proteomic techniques
ATE486285T1 (de) 2006-01-31 2010-11-15 Medical Res Fund Of Tel Aviv S Verfahren zur früherkennung von krebs

Similar Documents

Publication Publication Date Title
JP2009525041A5 (https=)
Binefa et al. Colorectal cancer: from prevention to personalized medicine
JP2010538609A5 (https=)
Pirrone et al. Olfactory detection of cancer by trained sniffer dogs: a systematic review of the literature
JP2015511121A5 (https=)
JP2013514074A5 (https=)
ES2772701T3 (es) Uso de nucleosomas libres de células como biomarcadores en muestras de esputo
ES2813829T3 (es) Métodos para la detección temprana del cáncer colorrectal
JP2012521772A (ja) 癌の診断及び癌処置のモニタリングのための方法
CN104278085B (zh) 一种与早发胃癌辅助诊断相关的snp标志物及其应用
Masoumzade et al. A medical encyclopedia with new approach graphene quantum dots for anti-breast cancer applications: mini review
ES2436667B1 (es) Suero biomarcador para diagnosticar el cáncer colorrectal
CN120505421A (zh) 一种用于辅助诊断结直肠癌的eRNA分子标记物及其应用
CN109628594A (zh) 一种与肝癌相关的长链非编码rna及其应用
JP2008539782A5 (https=)
Ni et al. Quantitative analysis of the expression of p53 gene in colorectal carcinoma by using real-time PCR
Kawin Leelawat et al. No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells
Kure et al. Breast Cancer Detection from a Urine Sample by Dog Sniffing
ES2393709B1 (es) Huella genómica para la predicción de la respuesta clínica a terapia antitumoral en cáncer colorrectal.
Türker et al. Kolon kanserinde lokalizasyon ile nötrofil lenfosit oranı arasındaki ilişki
Bakkar et al. Circulating miR-155 as a potential biomarker in Egyptian female patients with breast cancer
Gomez Mutational evaluation of TP53 gene in the canine hepatocellular carcinoma: a comparative approach
Karn et al. Colorectal cancer: Advances in diagnostic research
RU2006104863A (ru) Способ ранней диагностики рака предстательной железы
Porel et al. Emerging molecularly imprinted polymer innovations for targeting ovarian cancer